Category: Supply Chain

US shuffles $10B COVID-19 aid from testing to buy more vaccines, treatments

After failing to pass another COVID-19 relief package, the federal government is veering off course and investing $10 billion for vaccines and the antiviral treatment Paxlovid originally marked for tests and personal protective equipment, The New York …

Top 25 supply chain programs in 2022

Technology research firm Gartner ranked 55 supply chain undergraduate programs and graded the top 25 in North America. 

Abbott resumes baby formula production & 4 more supply chain updates

Four supply chain updates from the last week that ASC leaders need to know:

PPE manufacturer adds factory, expects to make 4.3B nitrile gloves

With a $150 million check, medical supply company Health Supply US will break ground in Greenville, S.C., with a new Glove One factory. 

More baby formula taking flight: 5 shortage updates

President Joe Biden’s Operation Fly Formula tacked on a fifth flight to import baby formula amid the national shortage. The plane from Cologne, Germany, will land on a runway in Fort Worth, Texas, on June 9. 

Philips Respironics recalls all V60 ventilators over power issues 

Philips Respironics recalled all V60 and V60 Plus Ventilators on June 3 over a power issue that may cause the devices to shut down without an alarm.

US corrals 36K monkeypox vaccine doses

As the number of confirmed monkeypox national cases creeps up to 25 across 12 states as of June 5, the HHS has a stockpile of about 36,000 monkeypox vaccine doses, according to CNBC. 

Pfizer to operate 1st US plant producing Paxlovid ingredients

Biopharmaceutical company Pfizer will manufacture materials for the antiviral drug Paxlovid in Kalamazoo, Mich., after a $120 million investment for the treatment’s first stateside factory.

Abbott resumes baby formula production

The catalyst for the national baby formula shortage, Abbott’s plant in Sturgis, Mich., restarted production June 4 after a monthslong closure due to contamination. 

GE’s contrast dye plant nears 100% capacity

Production of an X-ray imaging dye at a Shanghai plant will resume at normal speed this week after COVID-19-related shutdowns halted supply in May.